Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Ciclesonide safe and equieffective to budesonide in the management of asthma

June 4, 2003

Schering AG researchers design lipoxin A4 analogues for allergy, inflammation, etc.

June 4, 2003

Novartis designs new PDE4 inhibitors with utility in asthma

June 4, 2003

Good efficacy and cardiovascular safety profile reported for cilomilast in COPD

June 3, 2003

Merck KGaA presents new agents able to inhibit PDE4 and TNF-alpha production

June 3, 2003

IL-9-neutralizing antibody effective in mouse model of asthma

June 2, 2003

Launch of Clarinex RediTabs

June 2, 2003

TAS-203 more effective than cilomilast in airways inflammation

June 2, 2003

Inhibition of lung inflammation reported for the macrolide Z-104657A in rats

June 2, 2003

SD-208 inhibits lung fibrosis induced by TGF-beta1 overexpression in rats

June 2, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...